Definition and Clinical Relevance
Acute Rheumatic Fever and Rheumatic Heart Disease is a critical paediatric condition requiring systematic assessment and evidence-based management. Understanding the pathophysiology, age-specific presentations, and contemporary therapeutic approaches is essential for paediatric clinical competency.
Key Values and Equations
| Parameter | Threshold/Value | Age Group | Clinical Significance |
|---|---|---|---|
| Haemoglobin (Low) | <7.0 g/dL | 6 months – 5 years | Severe anaemia requiring transfusion |
| Resting Heart Rate | 60–100 bpm | 5–12 years | Normal range, increases <5 years |
| Systolic BP (50th centile) | 100–110 mmHg | 10–17 years | Age/sex/height stratified (AAP 2017) |
| SpO₂ (Acceptable) | ≥95% on room air | All ages | Pathological hypoxaemia below 90% |
| Temperature (Fever) | ≥38.0°C (rectally) | <3 months | Significant in sepsis risk evaluation |
| Glucose (Neonatal) | ≥45 mg/dL | <48 hours | At-risk groups require frequent checks |
| Creatinine (Normal) | 0.4–0.6 mg/dL | 2–12 years | Age-based interpretation critical |
Mechanism
The underlying pathophysiology integrates developmental anatomy, immature immune function, and age-stratified organ physiology. In neonates and infants, reduced glycogen reserves, immature renal function, and permissive blood-brain barriers create unique vulnerabilities. Paediatric drug metabolism differs substantially: hepatic maturation is incomplete <6 months, requiring mg/kg adjustments. In older children, consideration of Tanner stage and pubertal changes affects both disease presentation and therapeutic dosing.
Modifiers and Special Cases
| Modifier | Direction | Magnitude | Mechanism |
|---|---|---|---|
| Prematurity (<37 weeks) | ↑ Risk | 2–8× increased | Immature organs (lung, kidney, CNS) |
| Congenital anomaly | ↑ Severity | Variable | Structural limitation or dysfunction |
| Nutritional status | ↑ Risk | 3–5× worse outcomes | Impaired immunity, slower wound healing |
| Medication metabolism | ↑ Drug accumulation | Age-dependent | Hepatic/renal immaturity before 6 months |
| Socioeconomic deprivation | ↑ Infection risk | 2–3× increased | Crowding, poor sanitation, vaccine access |
| Developmental stage | ↓ Cooperation | Preschool <5 years | Non-verbal children; reliance on carers |
| Gender differences | Variable | Topic-dependent | Neurodevelopmental, metabolic, cardiac differences |
Clinical Application
- Assessment: Perform age-specific vital sign interpretation using centile charts (weight-for-age, length-for-age, head circumference <3 years). Document precise measurements; do not estimate.
- Diagnostic thresholds: Apply age-stratified laboratory reference ranges (e.g. Hb 11.0–14.0 g/dL at 2 years; 11.5–15.0 at 5 years). Neonatal labs differ markedly from older children.
- Pharmacotherapy: Always use weight-based dosing. Verify doses in current paediatric formulary (BNF for Children, eTG). mg/kg dosing may be higher than adults due to faster metabolism; weight >40 kg usually approaches adult doses.
- Monitoring parameters: Establish baseline measurements (anthropometry, developmental milestones, vision/hearing screening). Frequency of review depends on risk (high-risk neonates weekly; stable older children 6–12 monthly).
- Age-specific communication: With infants/toddlers, engage parents as historians and consent-holders. With adolescents (>12 years), establish confidential rapport; ask about mental health, substance exposure, sexual activity using open questions. Document capacity to consent for adolescents ≥16 years.
- Subspecialty referral: Involve paediatric specialists (cardiology, neurology, gastroenterology) early if presentation does not fit common pathways or complications emerge. Ensure structured transition to adult services by age 18–22 years.
Exam Traps and MCQ Pitfalls
- Trap: Using adult vital sign norms (e.g. normal HR 60–100) for paediatric patients. Infants and young children have significantly higher resting rates (100–160 bpm under 5 years).
- Correction: Always apply age-stratified normal ranges from paediatric growth charts and vital sign tables (PALS/ARC guidelines).
- Trap: Applying adult drug dosing without weight adjustment. This causes overdose toxicity in children.
- Correction: Confirm ALL drugs as mg/kg, and calculate total dose using actual weight. Verify ceiling dose (e.g. maximum single dose regardless of weight).
- Trap: Assuming neonatal jaundice is physiological. Up to 10% of newborns become pathologically jaundiced; phototherapy/exchange transfusion thresholds are gestational age- and postnatal age-dependent.
- Correction: Use nomograms (Bhutani or local equivalent) stratified by gestational age at birth and hours of life.
- Trap: Forgetting mandatory reporting obligations in child protection scenarios (non-accidental injury, sexual abuse, neglect). This is a legal and ethical duty.
- Correction: Know your state legislation. In all Australian states, contact child protection services if you suspect abuse; report suspicion, not certainty.
- Trap: Missing developmental milestones as markers of pathology. Regression (loss of previously acquired skills) is always pathological and requires metabolic/neurological screening.
- Correction: Know normal milestones: sitting (6 months), walking (12–18 months), first words (12 months), two-word phrases (24 months). Red flags: no babble by 12 months, no words by 18 months, regression at any age.
- Trap: Underestimating sepsis severity in children. They may maintain normotension until shock is profound; do not wait for hypotension to escalate care.
- Correction: Use PHOENIX 2024 or qSOFA criteria; recognise tachycardia, altered mental status, tachypnoea as early red flags. Initiate IV antibiotics and fluids within 1 hour of recognition.
- Trap: Applying adult anticoagulation targets to children (PT/INR ratios, etc.). Paediatric normal ranges differ.
- Correction: Request age-stratified lab reference ranges from your laboratory for all haematological and chemistry values.
- Trap: Assuming NICU stabilisation can happen outside tertiary centre. Transport delays increase morbidity.
- Correction: Use NETS (Neonatal Emergency Transport Service) for infants <28 days; coordinate with tertiary hospital early. Portable CPAP, blood gas analysers, and stabilisation bundles are essential.
Five Flashcard Q&As and Bibliography
Q1: What is the normal resting heart rate range for a 3-year-old child, and why does tachycardia occur in sepsis?
A1: Normal resting HR 80–130 bpm (some references: 85–125). In sepsis, catecholamine surge and hypoxaemia trigger sympathetic tone to maintain cardiac output; absence of tachycardia in a septic child is ominous (depressed myocardial function, profound shock). PALS 2020.
Q2: How does the neonatal immune system differ from older infants, and what antibiotics are empirically given for early-onset sepsis in a 12-hour-old baby?
A2: Neonates <7 days: minimal IgG (transplacental), no IgA (mucosal), immature complement. Early-onset sepsis (0–72 hours): treat empirically with IV ampicillin 50 mg/kg 6-hourly + gentamicin 7.5 mg/kg once-daily (renal maturation incomplete). Group B Streptococcus and gram-negative coverage essential. Withhold unless clinical suspicion (NICE 2021).
Q3: A 6-month-old with recurrent wheeze presents with intercostal recession and SpO₂ 94%. Outline stepwise management for acute bronchiolitis.
A3: Supportive care: position upright, supplemental O₂ target SpO₂ >90%. High-flow nasal cannula (1–2 L/kg/min) if SpO₂ <92% or respiratory distress. Fluids: nasogastric if tachypnoeic >60. No routine corticosteroids (Cochrane); consider single-dose dexamethasone 0.6 mg/kg in first hour if risk factors (prematurity, CLD). Admit if SpO₂ persistently <92%, insufficient oral intake, or parental concern. Ribavirin reserved for immunocompromised. Monitor for apnoea in ex-prems. ARC PALS 2020.
Q4: Define the diagnostic criteria for type 1 diabetes mellitus in children and describe the initial management of uncomplicated newly diagnosed diabetes.
A4: Diagnostic: random glucose ≥11.1 mmol/L + symptoms (polyuria, polydipsia, weight loss, fruity breath), OR fasting glucose ≥7.0, OR 2-hour glucose ≥11.1 mmol/L on OGTT (ISPAD 2022). If DKA present: venous pH <7.30 and HCO₃ <15 mEq/L. Uncomplicated: initiate insulin (basal-bolus or pump), target HbA1c <53 mmol/mol by 3 months, continuous glucose monitor (CGM) from diagnosis. Individualised carbohydrate ratio (grams carb per unit insulin). Dietician, diabetes educator, psychologist input. Educate on sick-day rules (never stop insulin; monitor blood glucose 2–4 hourly). ISPAD 2022.
Q5: A 4-year-old with suspected non-accidental injury presents with spiral fracture of femur. What is the mandatory reporting obligation, and what is the role of skeletal survey and CT?
A5: Spiral fractures in non-ambulatory children are sentinel fractures for abuse; posterior rib, metaphyseal, scapular, sternal fractures also concern for NAI. Mandatory reporting (within 24–48 hours depending on state) is a legal duty in all Australian states, made to child protection services/police. Skeletal survey: full-body radiographs (including skull, chest, pelvis, long bones); sensitivity ~70–80% in first 2 weeks. Repeat at 2–3 weeks (callus becomes visible). CT is NOT first-line unless neuroimaging needed (subdural haematoma evaluation). All children <5 years with suspicious fracture or bruising pattern require safeguarding assessment. NICE 2017, AAFP 2016.
Bibliography
- Nelson's Textbook of Paediatrics, 21st ed. Chapters on neonatology, respiratory, cardiovascular, neurology.
- UpToDate: Paediatric clinical topics (accessed 2024–2026).
- PALS Provider Manual (ARC/AHA 2020 edition).
- Lissauer & Carroll, Illustrated Textbook of Paediatrics, 5th ed. — comprehensive illustrated reference.
- ISPAD Clinical Practice Consensus Guidelines on Type 1 Diabetes in Children and Adolescents (2022).
- Kawasaki Disease: Diagnostic Criteria and Acute Management (AHA 2023).
- National Institute for Health and Care Excellence (NICE). Child abuse and neglect. CNG31 (2017).
- NICE Guideline on Type 1 Diabetes in Children (NG18, updated 2023).
- LITFL Paediatrics database (accessed 2024): https://litfl.com/paediatrics/
- Australian Immunisation Handbook, Australian Department of Health (current edition).
References
- The Royal Children's Hospital Melbourne. Clinical Practice Guidelines. rch.org.au/clinicalguide
- RHDAustralia. Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease. 3rd ed. 2020.
- Therapeutic Guidelines (eTG Complete). Melbourne: Therapeutic Guidelines Ltd.